DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS. et al.
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: A multicenter, open-label, randomized, phase III, noninferiority trial.
Ann Oncol 2019;
30: 788-95
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.